Paper29554376
High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.
Karpouzas GA and 4 others. Rheumatology (Oxford), 2018. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis. Papers, record 29554376. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29554376
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthritis, Rheumatoid | Major topic |
| Coronary Artery Disease | Major topic |
| Coronary Vessels | Major topic |
| Plaque, Atherosclerotic | Major topic |
| Troponin I | Major topic |
| Aged | |
| Biomarkers | |
| Computed Tomography Angiography | |
| Coronary Angiography | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Multidetector Computed Tomography | |
| Prospective Studies |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04056039 | Atorvastatin vs Colchicine in Decrease of Troponin I of High Sensitivity in Patients With Rheumatoid Arthritis. | Background |
Source ClinicalTrials.gov
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41415106 | Silymarin attenuates cardiac injury and inflammation in adjuvant-induced rheumatoid arthritis rats through activation of the Nrf2/SLC7A11/GPX4 signaling pathway. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/41415106 | PubMed |
| 41245987 | Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis. | Am J Prev Cardiol | 2025 | https://conductscience.org/library/papers/41245987 | PubMed |
| 39719397 | Changes in serum cholesterol loading capacity are linked to coronary atherosclerosis progression in rheumatoid arthritis. | RMD Open | 2024 | https://conductscience.org/library/papers/39719397 | PubMed |
| 39540283 | Emerging Imaging Techniques for Atherosclerosis in Systemic Immune-Mediated Inflammatory Conditions. | Arterioscler Thromb Vasc Biol | 2025 | https://conductscience.org/library/papers/39540283 | PubMed |
| 38879189 | The Association Between High-Sensitivity Cardiac Troponin T and Major Adverse Cardiovascular Events in Rheumatoid Arthritis. | J Rheumatol | 2024 | https://conductscience.org/library/papers/38879189 | PubMed |
| 38541031 | Assessment of Arterial Stiffness and Biochemical Markers in Systemic Lupus Erythematosus in the Diagnosis of Subclinical Atherosclerosis. | J Pers Med | 2024 | https://conductscience.org/library/papers/38541031 | PubMed |
| 37853434 | The use of high-sensitivity cardiac troponin I in assessing cardiac involvement and Disease prognosis in idiopathic inflammatory myopathy. | Adv Rheumatol | 2023 | https://conductscience.org/library/papers/37853434 | PubMed |
| 36763689 | High-sensitivity cardiac troponin T is associated with disease activity in patients with inflammatory arthritis. | PLoS One | 2023 | https://conductscience.org/library/papers/36763689 | PubMed |
| 36094601 | High-sensitivity cardiac troponin I is a biomarker for increased arterial stiffness in systemic lupus erythematous women with normal kidney function. | Rheumatol Int | 2023 | https://conductscience.org/library/papers/36094601 | PubMed |
| 35261189 | Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study. | Arthritis Rheumatol | 2022 | https://conductscience.org/library/papers/35261189 | PubMed |
| 33615723 | Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation. | Arthritis Rheumatol | 2021 | https://conductscience.org/library/papers/33615723 | PubMed |
| 33170072 | Association Among Noncalcified Coronary Burden, Fractional Flow Reserve, and Myocardial Injury in Psoriasis. | J Am Heart Assoc | 2020 | https://conductscience.org/library/papers/33170072 | PubMed |
| 32406000 | Cardiovascular events prediction by left ventricular longitudinal strain and serum high-sensitivity troponin I in patients with axial spondyloarthritis. | Clin Rheumatol | 2020 | https://conductscience.org/library/papers/32406000 | PubMed |
| 31646356 | Prevalence of high-sensitivity cardiac troponin T in real-life cohorts of psoriatic arthritis and general population: a cross-sectional study. | Rheumatol Int | 2020 | https://conductscience.org/library/papers/31646356 | PubMed |
| 30656399 | [Cardiovascular comorbidities in rheumatoid arthritis]. | Z Rheumatol | 2019 | https://conductscience.org/library/papers/30656399 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29554376
GET https://conductscience.org/api/papers/v1/29554376/authors